Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCQ | Q04759 | 15/20 | 1.00 |
| ▸ | PRKD3 | O94806 | 10/20 | 1.00 |
| ▸ | PRKCG | P05129 | 10/20 | 1.00 |
| ▸ | PRKCZ | Q05513 | 10/20 | 1.00 |
| ▸ | PRKCD | Q05655 | 10/20 | 1.00 |
| ▸ | PRKCB | P05771 | 9/20 | 1.00 |
| ▸ | PRKCA | P17252 | 9/20 | 1.00 |
| ▸ | PRKCH | P24723 | 9/20 | 1.00 |
| ▸ | PRKCI | P41743 | 9/20 | 1.00 |
| ▸ | PRKCE | Q02156 | 9/20 | 1.00 |
| ▸ | PRKD1 | Q15139 | 9/20 | 1.00 |
| ▸ | ROCK2 | O75116 | 7/20 | 1.00 |
| ▸ | EGFR | P00533 | 7/20 | 1.00 |
| ▸ | PRKACA | P17612 | 7/20 | 1.00 |
| ▸ | PRKACG | P22612 | 6/20 | 1.00 |
| ▸ | PRKACB | P22694 | 6/20 | 1.00 |
| ▸ | SRC | P12931 | 4/20 | 1.00 |
| ▸ | CHEK1 | O14757 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | KDR | P35968 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Staurosporine SCHEMBL12245439 | 1.00 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL8157 | 1.00 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL14264595 | 1.00 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL23768489 | 1.00 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL13659665 | 1.00 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL23793206 | 1.00 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL17397398 | 1.00 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| SCHEMBL24393902 | 1.00 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL21312855 | 1.00 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL14554228 | 1.00 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 35483 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146275-A1 | METHODS OF PRODUCING POLYPEPTIDES USING A CELL LINE RESISTANT TO APOPTOSIS | GENENTECH, INC. (US) | 2026-05-28 | — | — | US | claimed |
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| EP-4735586-A1 | CELLULAR REPROGRAMMING | Samuel, Amy Jane (NZ) | 2026-05-06 | — | — | EP | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026087680-A1 | TREATMENT FOR CARDIOVASCULAR DISEASE | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| WO-2026090557-A1 | SYSTEMS AND METHODS FOR PROCESSING ISM AND MCAS CLINICAL TRIAL DATA | TELIOS PHARMA INC. (US) | 2026-04-30 | — | — | WO | claimed |
| WO-2026087695-A1 | TREATMENT FOR METABOLIC DISORDER | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4709377-A2 | METHODS OF TREATMENT AND DIAGNOSIS OF PARKINSON'S DISEASE ASSOCIATED WITH WILD-TYPE LRRK2 | Neuron23, Inc. (US) | 2026-03-18 | — | — | EP | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-5093330-A | Selective inhibitors of proteinkinase c | CIBA-GEIGY CORPORATION (US) | 1992-03-03 | — | — | US | claimed |
| EP-0457295-A2 | Use of a modulator of protein phosphorylation in the treatment of amyloidosis associated with Alzheimer's disease | THE ROCKEFELLER UNIVERSITY (US) | 1991-11-21 | — | — | EP | claimed |
| EP-0444503-A2 | Staurosporine fermentation process | Bristol-Myers Squibb Company (US) | 1991-09-04 | — | — | EP | claimed |
| EP-0372062-A4 | INHIBITION OF LIPOGENESIS | — | 1991-04-17 | — | — | EP | claimed |
| US-4973552-A | Staurosporine fermentation process | BRISTOL-MEYERS SQUIBB COMPANY (US) | 1990-11-27 | — | — | US | claimed |
| EP-0383919-A1 | STAUROSPORIN DERIVATIVES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1990-08-29 | — | — | EP | claimed |
| US-4952567-A | Inhibition of lipogenesis | CITY OF HOPE (US) | 1990-08-28 | — | — | US | claimed |
| EP-0372062-A1 | INHIBITION OF LIPOGENESIS | CITY OF HOPE (US) | 1990-06-13 | — | — | EP | claimed |
| WO-1989011295-A1 | INHIBITION OF LIPOGENESIS | DEMEYTS PIERRE (US) | 1989-11-30 | — | — | WO | claimed |
| US-4735939-A | Insecticidal activity of staurosporine | THE DOW CHEMICAL COMPANY (US) | 1988-04-05 | — | — | US | claimed |